stock.name

Vaxcyte Inc

PCVX

Market Cap$8.05B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Vaxcyte IncVaxcyte Inc00%---
$3.79

Current Fair Value

94.8% downside

Overvalued by 94.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$8.05 Billion
Enterprise Value-
Dividend Yield$0.0 (0.0%)
Earnings per Share$0.0
Beta0.0
Outstanding Shares108,795,188
Avg 30 Day Volume552,912

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio0.0
PEG-
Price to Sales-
Price to Book Ratio-
Enterprise Value to Revenue-
Enterprise Value to EBIT-
Enterprise Value to Net Income-
Total Debt to Enterprise-
Debt to Equity-

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Vaxcyte Inc

14,000 employees
CEO: Grant Pickering

Vaxcyte is a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide. The Company’s cell-fre...